• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植受者的念珠菌血症:采用氟康唑预防后的危险因素演变

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

作者信息

Marr K A, Seidel K, White T C, Bowden R A

机构信息

Fred Hutchinson Cancer Research Center Program in Infectious Diseases, University of Washington Department of Medicine, Seattle, Washington, USA.

出版信息

J Infect Dis. 2000 Jan;181(1):309-16. doi: 10.1086/315193.

DOI:10.1086/315193
PMID:10608780
Abstract

The prophylactic use of fluconazole is common in blood and marrow transplant (BMT) recipients. To evaluate how fluconazole has influenced the development of azole resistance and candidemia, weekly mouthwashings were done, and fluconazole susceptibility was determined for 1475 colonizing and invasive isolates obtained from patients undergoing BMT. Of 585 patients, 256 (44%) were colonized with Candida species during the course of BMT. Of these, 136 patients (53%) had at least 1 mouthwashing sample that yielded Candida species other than C. albicans on culture. Only 4.6% of patients developed candidemia. Overall, C. albicans was the most common colonizing isolate, but it caused only 7% of cases of candidemia. About 5% of colonizing C. albicans strains and 100% (2 of 2) invasive C. albicans strains were fluconazole-resistant. Colonization, cytomegalovirus disease, and bacteremia are risk factors for the development of candidemia. The use of prophylactic fluconazole is associated with a low incidence of candidemia and attributable mortality, despite colonization with azole-resistant Candida species in BMT recipients.

摘要

氟康唑的预防性使用在血液和骨髓移植(BMT)受者中很常见。为了评估氟康唑如何影响唑类耐药性和念珠菌血症的发生,我们进行了每周一次的口腔冲洗,并对从接受BMT的患者中获得的1475株定植和侵袭性分离株进行了氟康唑敏感性测定。在585例患者中,256例(44%)在BMT过程中被念珠菌属定植。其中,136例患者(53%)至少有1份口腔冲洗样本在培养时分离出白色念珠菌以外的念珠菌属。只有4.6%的患者发生了念珠菌血症。总体而言,白色念珠菌是最常见的定植分离株,但它仅导致7%的念珠菌血症病例。约5%的定植白色念珠菌菌株和100%(2/2)的侵袭性白色念珠菌菌株对氟康唑耐药。定植、巨细胞病毒病和菌血症是念珠菌血症发生的危险因素。尽管BMT受者中存在对唑类耐药的念珠菌属定植,但预防性使用氟康唑与念珠菌血症的低发病率和可归因死亡率相关。

相似文献

1
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.异基因造血干细胞移植受者的念珠菌血症:采用氟康唑预防后的危险因素演变
J Infect Dis. 2000 Jan;181(1):309-16. doi: 10.1086/315193.
2
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.高危异基因骨髓移植后光滑念珠菌和克柔念珠菌血症:低剂量氟康唑预防对发病率和结局无不良影响
Bone Marrow Transplant. 2001 Nov;28(9):873-8. doi: 10.1038/sj.bmt.1703252.
3
Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.接受大剂量化疗和自体骨髓移植治疗的乳腺癌女性患者的念珠菌血症。
Cancer. 2003 Jul 1;98(1):24-30. doi: 10.1002/cncr.11470.
4
Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.骨髓移植期间使用低剂量氟康唑进行抗真菌预防。骨髓移植团队。
Bone Marrow Transplant. 1994 Dec;14(6):919-24.
5
Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.对极低出生体重儿进行氟康唑预防可降低侵袭性念珠菌病的死亡率,且不会出现耐氟康唑的念珠菌物种。
Pediatrics. 2008 Apr;121(4):703-10. doi: 10.1542/peds.2007-1130.
6
Factors influencing the performance level of Candida mannan antigen testing in allogeneic stem cell transplant recipients not receiving fluconazole prophylaxis.影响未接受氟康唑预防治疗的异基因干细胞移植受者中念珠菌甘露聚糖抗原检测性能水平的因素。
Transpl Infect Dis. 2011 Jun;13(3):266-72. doi: 10.1111/j.1399-3062.2010.00593.x. Epub 2010 Dec 22.
7
Fluconazole prophylaxis and Candida fungemia in neutropenic children with malignancies.氟康唑预防与恶性肿瘤中性粒细胞减少儿童的念珠菌血症
Haematologica. 1993 Jul-Aug;78(4):249-51.
8
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.血液系统恶性肿瘤患者中由对氟康唑耐药且对伏立康唑敏感性降低的白色念珠菌引起的突破性真菌血症。
Haematologica. 2006 Feb;91(2):287-8.
9
Risk factors for candidemia-related mortality at a medical center in central Taiwan.台湾中部某医学中心念珠菌血症相关死亡率的危险因素。
J Microbiol Immunol Infect. 2006 Apr;39(2):155-61.
10
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.2019例念珠菌血症患者的流行病学及转归:来自前瞻性抗真菌治疗联盟登记处的数据
Clin Infect Dis. 2009 Jun 15;48(12):1695-703. doi: 10.1086/599039.

引用本文的文献

1
Risk factors and outcome for bloodstream infections due to fluconazole-resistant Candida parapsilosis: a 22-year single-center retrospective study.耐氟康唑近平滑念珠菌血流感染的危险因素及结局:一项为期22年的单中心回顾性研究。
Antimicrob Resist Infect Control. 2025 May 14;14(1):49. doi: 10.1186/s13756-025-01559-w.
2
Azole resistance: patterns of amino acid substitutions in Candida sterol 14α-demethylase.唑类抗性:白色念珠菌固醇14α-去甲基酶中的氨基酸取代模式
Antonie Van Leeuwenhoek. 2025 Apr 17;118(5):68. doi: 10.1007/s10482-025-02080-1.
3
Antiviral potential of Vδ2 T cells in children given TCR αβ/CD19 cell-depleted HLA-haploidentical HSCT.
接受TCR αβ/CD19细胞去除的HLA单倍型相合造血干细胞移植的儿童中Vδ2 T细胞的抗病毒潜力
Blood Adv. 2025 Mar 11;9(5):990-1002. doi: 10.1182/bloodadvances.2024013902.
4
Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020.突破恶性血液病伴发的念珠菌血症:来自日本 2009 年至 2020 年单中心回顾性研究的结果。
Med Mycol. 2023 Jun 5;61(6). doi: 10.1093/mmy/myad056.
5
Whole-Genome Sequence Analysis of Isolates from a Patient with Persistent Fungemia and Determination of the Molecular Mechanisms of Multidrug Resistance.对一名持续性真菌血症患者的分离菌株进行全基因组序列分析并确定多重耐药的分子机制
J Fungi (Basel). 2023 Apr 26;9(5):515. doi: 10.3390/jof9050515.
6
Invasive candidiasis: current clinical challenges and unmet needs in adult populations.侵袭性念珠菌病:成人患者的当前临床挑战和未满足的需求。
J Antimicrob Chemother. 2023 Jul 5;78(7):1569-1585. doi: 10.1093/jac/dkad139.
7
Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients With Bloodstream Infection.血流感染患者氟康唑耐药临床预测模型的创建与内部验证
Open Forum Infect Dis. 2022 Aug 30;9(9):ofac447. doi: 10.1093/ofid/ofac447. eCollection 2022 Sep.
8
Fungal Infected Adipose Stem Cells: The Effects of Novel Lipo-Niosome Nanoparticles Loaded with Amphotericin B and Thymus Essential Oil.真菌感染的脂肪干细胞:负载两性霉素B和胸腺精油的新型脂质-非离子表面活性剂纳米粒的作用
Cell J. 2022 Jul 27;24(7):391-402. doi: 10.22074/cellj.2022.7967.
9
Continuing Shifts in Epidemiology and Antifungal Susceptibility Highlight the Need for Improved Disease Management of Invasive Candidiasis.流行病学和抗真菌药敏性的持续变化凸显了改善侵袭性念珠菌病疾病管理的必要性。
Microorganisms. 2022 Jun 13;10(6):1208. doi: 10.3390/microorganisms10061208.
10
Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area.异基因造血干细胞移植后巨细胞病毒感染与侵袭性真菌感染之间关联的再探讨:来自高巨细胞病毒血清阳性率地区的真实世界分析
J Fungi (Basel). 2022 Apr 16;8(4):408. doi: 10.3390/jof8040408.